COVID Risk | Literature database and meta-analysis page 14

Last update : 2021-08-05 08:37:15 (GMT+2) | 276 factors investigated | 1766 estimates included | 219 articles processed | QC progress: 50%

Receive updates on COVID-19 risk factors

Associated factors

Risk category:

Risk name:

Outcomes

Outcome description:

Filters

Adjusted analysis:

Author:

Reset
Run a meta-analysis by selecting an Outcome & a Risk category or a Risk name & a Risk category, and click on the Submit button.

Green: significant protective factor
Red: significant risk factor
^§ adjusted estimate (see article details)
^† estimated using data reported in the article

Outcome	Risk category	Risk [exposed vs. unexposed]	Risk estimate (95% CI)	Author [URL]	View	QC
COVID-19 in children (severe/critical)	Symptoms	Symptomatic SARS COV-2 infection [Present vs. Not present]	Odds ratio: 3.190 (1.950-5.210)	Lu
COVID-19 in children (any condition)	Findings	Chest radiologic findings [Pneumonia vs. Normal]	Odds ratio: 8.450 (2.690-26.610) ^§	Lu
COVID-19 in children (any condition)	Laboratory Findings	hs-CRP [Abnormal vs. Normal]	Odds ratio: 4.890 (1.100-21.750) ^§	Lu
COVID-19 (severe/critical)	Other	Childhood BCG vaccination [Present vs. Not present]	Odds ratio: 0.966 (0.060-15.462)	Hamiel
COVID-19 in children (any condition)	Patient characteristics	Age [<6 years vs. >=6 years]	Odds ratio: 8.940 (2.550-31.350) ^§	Lu
SARS COV-2 infection	Other	Childhood BCG vaccination [Present vs. Not present]	Odds ratio: 1.219 (1.025-1.450)	Hamiel
COVID-19 (death)	Comorbidities	Heart disease [Present vs. Not present]	Relative risk: 2.350 (1.080-5.090)	Inciardi
COVID-19 (severe/fatal)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Hazard ratio: 0.970 (0.740-1.280) ^§	Geleris
COVID-19 (severe/fatal)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Hazard ratio: 1.000 (0.760-1.320) ^§	Geleris
COVID-19 (severe/fatal)	Treatment	Treatment for COVID-19 [Treated with hydroxychloroquine vs. Not received]	Hazard ratio: 2.370 (1.840-3.020)	Geleris
COVID-19 (severe/critical)	Laboratory Findings	WBC [1 unit increase vs. Not applicable]	Odds ratio: 0.972 (0.807-1.170) ^§	Huang
COVID-19 (severe/critical)	Laboratory Findings	NLR [1 unit increase vs. Not applicable]	Odds ratio: 1.182 (1.051-1.329) ^§	Huang
COVID-19 (severe/critical)	Symptoms	Body temperature [Fever present vs. Normal]	Odds ratio: 5.084 (2.071-12.482) ^§	Huang
COVID-19 (severe/critical)	Symptoms	Sputum production [Present vs. Not present]	Odds ratio: 2.131 (0.950-4.782) ^§	Huang
COVID-19 (severe/critical)	Comorbidities	Coronary heart disease [Present vs. Not present]	Odds ratio: 5.106 (1.369-19.046) ^§	Huang
COVID-19 (severe/critical)	Comorbidities	Diabetes [Present vs. Not present]	Odds ratio: 2.261 (0.886-5.769) ^§	Huang
COVID-19 (severe/critical)	Patient characteristics	Age [1 year increase vs. Not applicable]	Odds ratio: 1.020 (0.995-1.046) ^§	Huang
COVID-19 (severe/critical)	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 1.768 (0.802-3.899) ^§	Huang
COVID-19 (severe/critical)	Status	Time from symptom onset to hospital admission [1 day increase vs. Not applicable]	Odds ratio: 1.075 (0.999-1.157) ^§	Huang
COVID-19 (severe/critical)	Symptoms	Body temperature [Fever present vs. Normal]	Odds ratio: 5.675 (2.341-13.757) ^§	Huang
COVID-19 (severe/critical)	Symptoms	Sputum production [Present vs. Not present]	Odds ratio: 2.456 (1.113-5.421) ^§	Huang
COVID-19 (severe/critical)	Comorbidities	Cancer [Present vs. Not present]	Odds ratio: 3.500 (0.659-18.593) ^§	Huang
COVID-19 (severe/critical)	Comorbidities	COPD [Present vs. Not present]	Odds ratio: 1.786 (0.343-9.302) ^§	Huang
COVID-19 (severe/critical)	Comorbidities	Cerebrovascular disease [Present vs. Not present]	Odds ratio: 1.576 (0.305-8.134) ^§	Huang
COVID-19 (severe/critical)	Comorbidities	Coronary heart disease [Present vs. Not present]	Odds ratio: 4.069 (1.068-15.497) ^§	Huang
COVID-19 (severe/critical)	Comorbidities	Diabetes [Present vs. Not present]	Odds ratio: 2.539 (1.014-6.356) ^§	Huang
COVID-19 (severe/critical)	Comorbidities	Hypertension [Present vs. Not present]	Odds ratio: 1.617 (0.676-3.867) ^§	Huang
COVID-19 (severe/critical)	Patient characteristics	Age [1 year increase vs. Not applicable]	Odds ratio: 1.018 (0.992-1.044) ^§	Huang
COVID-19 (severe/critical)	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 2.026 (0.906-4.529) ^§	Huang
COVID-19 (severe/critical)	Laboratory Findings	Platelet count [Abnormal vs. Normal]	Hazard ratio: 4.047 (1.313-12.472) ^§	Bi
COVID-19 (severe/critical)	Laboratory Findings	Fibrinogen-to-Albumin Ratio [Abnormal vs. Normal]	Hazard ratio: 4.058 (1.246-13.222) ^§	Bi
COVID-19 (severe/critical)	Laboratory Findings	Fibrinogen [Abnormal vs. Normal]	Hazard ratio: 1.154 (0.339-3.927) ^§	Bi
COVID-19 (severe/critical)	Laboratory Findings	Prothrombin time [Abnormal vs. Normal]	Hazard ratio: 1.388 (0.373-5.168) ^§	Bi
COVID-19 (severe/critical)	Patient characteristics	Age [>50 years vs. <=50 years]	Hazard ratio: 1.299 (0.492-3.428) ^§	Bi
COVID-19 (death)	Status	Time from symptom onset to laboratory confirmation [unknown outcome vs. <=6 days]	Odds ratio: 1.410 (0.440-4.550) ^§	Deng
COVID-19 (death)	Status	Time from symptom onset to laboratory confirmation [>6 days vs. <=6 days]	Odds ratio: 1.410 (0.420-4.740) ^§	Deng
COVID-19 (death)	Status	Time from symptom onset to hospital admission [Unknown vs. <=3 days]	Odds ratio: 0.550 (0.180-1.690) ^§	Deng
COVID-19 (death)	Status	Time from symptom onset to hospital admission [>3 days vs. <=3 days]	Odds ratio: 0.650 (0.200-2.110) ^§	Deng
COVID-19 (death)	Status	Time from symptom onset to first healthcare consultation [Unknown vs. <=2 days]	Odds ratio: 0.400 (0.140-1.140) ^§	Deng
COVID-19 (death)	Status	Time from symptom onset to first healthcare consultation [>2 days vs. <=2 days]	Odds ratio: 1.110 (0.330-3.710) ^§	Deng
COVID-19 (death)	Other	Economic regions [China west and northeast region vs. China east region]	Odds ratio: 3.930 (1.740-8.850) ^§	Deng
COVID-19 (death)	Other	Economic regions [China central region vs. China east region]	Odds ratio: 3.450 (1.320-9.030) ^§	Deng
COVID-19 (death)	Patient characteristics	Gender [Male vs. Female]	Odds ratio: 2.020 (1.020-4.030) ^§	Deng
COVID-19 (death)	Patient characteristics	Age [1 year increase vs. Not applicable]	Odds ratio: 1.180 (1.140-1.220) ^§	Deng
COVID-19 (death)	Patient characteristics	Gender [Male vs. Female]	Relative risk: 1.290 (1.060-1.570) ^§	Yang
COVID-19 (death)	Patient characteristics	Age [1 year increase vs. Not applicable]	Relative risk: 1.030 (1.020-1.040) ^§	Yang
COVID-19 (death)	Laboratory Findings	Nadir platelet count [Abnormal (<50) vs. Normal (>=150)]	Relative risk: 13.680 (9.890-18.920) ^§	Yang
COVID-19 (death)	Laboratory Findings	Nadire platelet count [Abnornal (50-100) vs. Normal (>=150)]	Relative risk: 9.990 (7.160-13.940) ^§	Yang
COVID-19 (death)	Laboratory Findings	Nadir platelet count [Abndormal (100-150) vs. Normal (>=150)]	Relative risk: 3.420 (2.360-4.960)	Yang
COVID-19 (severe/fatal)	Laboratory Findings	D-dimer [Abnormal vs. Normal]	Odds ratio: 4.810 (1.470-15.690)	Zheng

If a relevant publication escaped our attention, please contact us.